Higher CD137 expression on B cells of CLL patients is observed when compared to other malignancies and healthy controls, and increased B cell proliferation upon CD137 signaling is mediated by the NF-κB pathway (24). The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.